OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
176
Results
Show all
Save search
Copy query
Show results for
Unknown
(167)
Transcriptomics
(5)
Proteomics
(4)
Organisms
Aerococcus urinae NBRC 15544 = CCUG 36881
(4)
Alteromonadales
(4)
Candida albicans SC5314
(4)
Canis lupus familiaris
(4)
Carya cathayensis
(4)
Ectopseudomonas oleovorans CECT 5344
(4)
Ensifer adhaerens
(4)
Enterococcus faecalis
(4)
Globicatella sanguinis
(4)
Halictus scabiosae
(4)
Histomonas meleagridis
(4)
Human immunodeficiency virus 1
(4)
Listeria monocytogenes
(4)
Listeria monocytogenes EGD-e
(4)
Methylohalobius crimeensis 10Ki
(4)
Mus musculus
(4)
Mycobacterium tuberculosis
(4)
Ophrys garganica
(4)
Ophrys sphegodes
(4)
Pseudomonas aeruginosa SJTD-1
(4)
Pseudomonas putida KT2440
(4)
Pyrococcus furiosus
(4)
Rabies virus Nishigahara RCEH
(4)
Rattus norvegicus
(4)
Rhizobium sp. Leaf68
(4)
Schizosaccharomyces pombe 927
(4)
Shigella
(4)
Mus musculus
(3)
Bifidobacterium breve UCC2003
(1)
Rattus norvegicus
(1)
Repository
biostudies-arrayexpress
(5)
pride
(4)
Tissue
Spermatozoon
(3)
Sperm
(2)
Cell culture
(1)
Seminal plasma
(1)
Disease
Reference
(1)
Technology Type
Mass Spectrometry
(4)
SWATH MS
(2)
Bottom-up proteomics
(1)
Shotgun proteomics
(1)
Publication Date
2007
(3)
2020
(2)
2012
(1)
2011
(1)
2019
(1)
2018
(1)
Study type
Transcription profiling by array
(4)
Comparative genomic hybridization by array
(1)
Release Date
2022
(30)
2025
(22)
2021
(16)
2024
(15)
2023
(15)
2019
(10)
2018
(10)
2020
(7)
2017
(7)
2015
(6)
2012
(5)
2011
(5)
2016
(5)
2009
(4)
2007
(3)
2014
(3)
2026
(2)
2010
(2)
2008
(2)
2006
(2)
2013
(1)
Lab affiliation
CSIRO Food Futures National Research Flagship, Division of Livestock Industries, Queensland Biosciences Precinct, St. Lucia, Queensland, Australia
(1)
Colorado Center for Reproductive Medicine
(1)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
(1)
School of Life and Environmental Sciences, Faculty of Science, University of Sydney, Australia
(1)
Previous
page
1 / 18
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
18
Next
page
Sort
by:
Relevance
Page size
10
T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity.
Not available
S-EPMC8864655
|
biostudies-literature
Cite
microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells.
Not available
S-EPMC2710921
|
biostudies-literature
Cite
Mycobacterium tuberculosis
-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4
+
T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways.
Not available
S-EPMC6783366
|
biostudies-literature
Cite
NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins.
Not available
S-EPMC3602998
|
biostudies-literature
Cite
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.
Not available
S-EPMC8335746
|
biostudies-literature
Cite
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies.
Not available
S-EPMC9481718
|
biostudies-literature
Cite
Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naive mice.
Not available
S-EPMC11495396
|
biostudies-literature
Cite
Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents.
Not available
S-EPMC11830968
|
biostudies-literature
Cite
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Not available
S-EPMC11061218
|
biostudies-literature
Cite
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Not available
S-EPMC9979709
|
biostudies-literature
Cite
Previous
page
1 / 18
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
18
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets